bpc 157 use in autuimmunity scholarly articles BPC-157 as an Investigational Peptide Therapeutic: Biopharmaceutical Challenges, Formulation Strategies, and Translational Development Barriers Wellness clinics promote the use
Description
Parsons RB, Smith EL, Waring RH, Ramsden DB
Gastrointestinal Research Applications As the natural source tissue for BPC-157, gastrointestinal healing represents core research applications including ulcer healing, inflammatory bowel disease treatment, and mucosal protection mechanisms
However, any spreading, painful, or breathing-related symptoms should prompt urgent care
VB12 (0.5 mg/day) or vehicle was injected intravenously at 12:30 h for 11 days, which was followed by oral administration (2 mg x 3/day) for 7 days
